DOI: https://doi.org/10.26641/2307-0404.2018.3(part1).142360

Bronchoectatic disease: the state of art and the clinical case.

T. O. Pertseva, K. Yu. Gashynova, V. V. Dmytrychenko, K. S. Suska

Abstract


In connection with the increased diagnostic capabilities of X-ray methods, bronchiectasis is increasingly being diagnosed today. The main problem of patients’ management is the heterogeneity of the etiological factors, as well as the lack of evidence base for the effectiveness of therapy. The article presents a clinical case of bronchiectasis in a patient with chronic carriage of Pseudomonas aeruginosa (mucoid strain) and Klebsiella pneumoniae.


Keywords


bronchoectatic disease; bronchiectasis; computed tomography; Pseudomonas aeruginosa

References


Pertseva TA, Kireyeva TV, Krykhtina MA. [Cur­rent view on pharmacotherapy of low respiratory tract infections: the place for macrolides]. Ukrayinskyi pulmo­nologichnyi zhurnal. 2015;3:49-55. Ukrainian.

Samsonova MV. [Bronchiectasis: a modern view of the problem]. Prakticheskaya pulmonologiya. 2017;1:75-76. Russian.

Feshchenko YuI, Dzyublik AYa. [Rational anti­biotic therapy of patients with infections of lower respiratory ways]. Ukrayinskyi pulmonologichnyi zhur­nal. 2009;4:5-8. Russian.

Aliberti S, Lonni S, Dore S et al. Clinical phenotypes in adult patients with bronchiectasis. Eur Res­pir J. 2016 Apr;47(4):1113-22. http://dx.doi.org/10.1183/­13993003.01899-2015

Miguel Angel, Martínez-García MD, Juan-Jose Soler-Cataluña MD et al. Factors Associated With Lung Function Decline in Adult Patients With Stable Non-Cystic Fibrosis Bronchiectasis. Chest. 2007Nov;132(5):1565-72.

Barker AF. Bronchiectasis. N. Engl. J. Med. 2002;346(18):1383-93. http://dx.doi.org/10.1056/NEJMra­012519

Luce Cantin, Alexander A Bankier, and Ronald L. Eisenberg. Bronchiectasis. American Journal of Roent­genology. 2009;193:158-71.

Chang AB, Grimwood K, Mulholland EK et al. Bronchiectasis in Indigenous children in remote Austra­lian communities. Med J. Aust. 2002;177:200-4.

McDonnell MJ, Aliberti S, Goeminne PC et al. Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts. Thorax. 2016;71:1110-8. http://dx.doi.org/10.1136/thoraxjnl-2016-208481

Lonni S, Chalmers JD, Goeminne PC, McDonnell MJ, Dimakou K, De Soyza A, Polverino E, Van de Kerk­hove C, Rutherford R, Davison J et al. Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity. Ann Am Thorac Soc. 2015;12(12):1764-70. http://dx.doi.org/10.1513/­AnnalsATS.201507-472OC

Finch S, McDonnell MJ, Abo-Leyah H et al. A comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchi­ectasis. Ann Am Thorac Soc. 2015;12:1602-11.

Finklea JD, Khan G, Thomas S et al. Predictors of mortality in hospitalized patients with acute exacerbation of bronchiectasis. Respir Med. 2010;104:816-21. http://dx.doi.org/10.1016/j.rmed.2009.11.021

Kwak HJ, Moon J-YY, Choi YW et al. High pre­valence of bronchiectasis in adults: analysis of CT fin­dings in a health screening program. Tohoku J Exp Med. 2010;222:237-42. http://dx.doi.org/10.1620/tjem.222.237

Loebinger MR, Wells AU, Hansell DM et al. Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. Eur Respir J. 2009;34:843-9. http://dx.doi.org/10.1183/09031936.00003709

Kyreeva T, Dmytrychenko V, Pertseva T, Bogats­ka K. Microbial landscape of sputum in patients with non-cystic fibrosis bronchiectasis. 2nd World Bronchiectasis Conference. 2017;52.

Mirsaeidi M, Hadid W, Ericsoussi B et al. Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis. International Journal of Infectious Diseases. 2013;17:1000-4. http://dx.doi.org/10.1016/j.ijid.2013.03.018.

Moulton BC, Barker AF. Pathogenesis of bronchiectasis. Clin Chest Med. 2012;33(2):211-7. http://dx.doi.org/10.1016/j.ccm.2012.02.004

Orriols R, Hernando R, Ferrer A et al. Eradication therapy against Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis. Respiration. 2015;90:299-305. http://dx.doi.org/10.1159/000438490

Polverino E, Goeminne PC, McDonnell MJ et al. European Respiratory Society guidelines for the ma­nagement of adult bronchiectasis. Eur Respir J. 2017;50. http://dx.doi.org/10.1183/13993003.00629-2017

Quint JK, Millett ER, Joshi M et al. Changes in the incidence, prevalence and mortality of bronchi­ectasis in the UK from 2004 to 2013: A population-based cohort study. Eur Respir J. 2016;47:186-193. http://dx.doi.org/10.1183/13993003.01033-2015

Rademacher J, Welte T. Bronchiectasis – diag­nosis and treatment. Deutsches Aerzteblatt Online. 2011;108:809-15.

Raghu G, King TE, Behr J et al. Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1). Eur Respir J. 2010;35:118-23. http://dx.doi.org/10.1183/09031936.00188108.

Ringshausen FC, de Roux A, Pletz MW et al. Bronchiectasis-associated hospitalizations in Germany, 2005-2011: a population-based study of disease burden and trends. PLoS One. 2013;8:e71109. http://dx.doi.org/10.1371/journal.pone.0071109

Seitz AE, Olivier KN, Steiner CA et al. Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006. Chest. 2010;138:944-9. http://dx.doi.org/10.1378/chest.10-0099

Pamela J McShane, Edward T Naureckas, Gregory Tino et al. Non–Cystic Fibrosis Bronchiectasis. AJRCCM. 2013 Sept;188:6.

Yu-xing Jin, Yi Zhang, Liang Duan, Yang Yang, Ge-ning Jiang, Jia-an Ding. Surgical treatment of bronchi­ectasis: A retrospective observational study of 260 patients. International Journal of Surgery. 2014;12(10):1050-4. http://dx.doi.org/10.1016/j.ijsu.2014.08.398

Tashkin DP, Celli B, Senn S et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359:1543-54. http://dx.doi.org/10.1056/NEJMoa0805800

Thurlbeck WM. Chronic airflow obstruction. Thurlbeck pathology of the lung 2nd edition. 1995;804-8.

Weycker D, Edelsberg J, Oster G et al. Preva­len­ce and economic burden of bronchiectasis. Clin Pulm Med. 2005;12:205-9. http://dx.doi.org/10.1097/01.cpm.0000171422.98696.ed.


GOST Style Citations


  1. Перцева Т.А. Современный взгляд на фар­макотерапию инфекций нижних дыхательных путей: место макролидов / Т.А. Перцева, Т.В. Киреева, М.А. Крыхтина // Укр. пульмонол. журнал. – 2015. – № 3. – С. 49-55.
  2. Самсонова М.В. Бронхоэктазы: современный взгляд на проблему / М.В. Самсонова, А.Л. Черняев, О.С. Леменкова // Практ. пульмонология. – 2017. – № 1. – С. 75.
  3. Фещенко Ю.И. Рациональная антибиотикоте­рапия больных с инфекциями нижних дыхательных путей / Ю.И. Фещенко, А.Я. Дзюблик. // Укр. пульмо­нол. журнал. – 2009. – № 4. – С. 5-8.
  4. Aliberti S. Clinical phenotypes in adult patients with bronchiectasis / S. Aliberti, S. Lonni, S. Dore // Eur. Respir. J. – 2016. – Vol. 47. – P. 1113-1122.
  5. Angel M. Factors Associated With Lung Function Decline in Adult Patients With Stable Non-Cystic Fib­rosis Bronchiectasis / M. Angel, Martínez-García, J. So­ler-Cataluña // Chest. – 2007. – Vol. 132. – P. 1565-1572.
  6. Barker A. Bronchiectasis / A. Barker // N. Engl. J. Med. – 2002. – Vol. 346. – P. 1383-1393.
  7. Cantin L. Bronchiectasis / L. Cantin, A. Bankier, R. Eisenberg // Am. J. Roentgenology. – 2009. – Vol. 193. – P. 158-171.
  8. Chang A. Bronchiectasis in Indigenous children in remote Australian communities / A. Chang, K. Grim­wood, E. Mulholland // Med. J. Aust. – 2002. – Vol. 177. – P. 200-204.
  9. McDonnell M. Multidimensional severity asses­sment in bronchiectasis: an analysis of seven European cohorts / M. McDonnell, S. Aliberti, P. Goeminne // Tho­rax. – 2016. – Vol. 71. – P. 1110-1118.
  10. Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity / S. Lonni, J. Chalmers, P. Goeminne [et al.] // Ann. Am. Thorac. Soc. – 2015. – N 12. – P. 1764-1770.
  11. Finch S. A comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis / S. Finch, M. McDonnell, H. Abo-Leyah // Ann. Am. Thorac. Soc. – 2015. – N 12. – P. 1602-1611.
  12. Finklea J. Predictors of mortality in hospitalized patients with acute exacerbation of bronchiectasis / J. Finklea, G. Khan, S. Thomas // Respir. Med. – 2010. – Vol. 104. – P. 816-821.
  13. Kwak H. High prevalence of bronchiectasis in adults: analysis of CT findings in a health screening program / H. Kwak, J. Moon, Y. Choi // Tohoku J. Exp. Med. – 2010. – Vol. 222. – P. 237-242.
  14. Loebinger M. Mortality in bronchiectasis: a long-term study assessing the factors influencing survival / M. Loebinger, A. Wells, D. Hansell // Eur. Respir. J. – 2009. – Vol. 34. – P. 843-849.
  15. Microbial landscape of sputum in patients with non-cystic fibrosis bronchiectasis / T.Kyreeva, V. Dmyt­rychenko, T. Pertseva, K. Bogatska // 2nd World Bron­chiectasis Conference. – 2017. – P. 52.
  16. Mirsaeidi M. Non-tuberculous mycobacterial di­sease is common in patients with non-cystic fibrosis bronchiectasis / M. Mirsaeidi, W. Hadid, B. Ericsoussi // Inter. J. Infectious Diseases. – 2013. – N 17. – P. 1000-1004.
  17. Moulton B. Pathogenesis of bronchiectasis / B. Moulton, A. Barker // Clin Chest. Med. – 2012. – Vol. 33. – P. 211-217.
  18. Orriols R. Eradication therapy against Pseudo­monas aeruginosa in non-cystic fibrosis bronchiectasis / R. Orriols, R. Hernando, A. Ferrer // Respiration. – 2015. – Vol. 90. – P. 299-305.
  19. Polverino E. European Respiratory Society gui­delines for the management of adult bronchiectasis / E. Polverino, P. Goeminne, M. McDonnell // Eur. Respir. J. – 2017. – Vol. 50.
  20. Quint J. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: A population-based cohort study / J. Quint, E. Millett, M. Joshi // Eur. Respir. J. – 2016. – Vol. 47. – P. 186-193.
  21. Rademacher J. Bronchiectasis – diagnosis and treatment / J. Rademacher, T. Welte // Deutsches Aerz­teb­latt Online. – 2011. – Vol. 108. – P. 809-815.
  22. Raghu G. Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1) / G. Raghu, T. King, J. Behr // Eur. Respir. J. – 2010. – Vol. 35. – P. 118-123.
  23. Ringshausen F. Bronchiectasis-associated hospi­talizations in Germany, 2005-2011: a population-based stu­dy of disease burden and trends / F. Ringshausen, A. de Roux, M. Pletz // PLoS One. – 2013. – N 8. – P. e71109.
  24. Seitz A. Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006 / A. Seitz, K. Olivier, C. Steiner // Chest. – 2010. – N 138. – P. 944-949.
  25. McShane P. Non–Cystic Fibrosis Bronchiectasis / P. McShane, E. Naureckas, G. Tino. // AJRCCM. – 2013. – N 188. – P. 6.
  26. Surgical treatment of bronchiectasis: A retro­spec­tive observational study of 260 patients / Y. Jin, Y.Zhang, L. Duan [et al.] // Inter. J. Surgery. – 2014. – N 12. – P. 1050-1054.
  27. Tashkin D. A 4-year trial of tiotropium in chronic ob­structive pulmonary disease / D. Tashkin, B. Celli, S. Senn // N. Engl. J. Med. – 2008. – Vol. 359. – P. 1543-1554.
  28. Thurlbeck W. Chronic airflow obstruction / W.M Thurlbeck // Thurlbeck pathology of the lung 2nd edition. – 1995. – P. 804-808.
  29. Weycker D. Prevalence and economic burden of bronchiectasis. / D. Weycker, J. Edelsberg, G. Oster // Clin. Pulm. Med. – 2005. – N 12. – P. 205-209.




 

This work is licensed under a Creative Commons Attribution 4.0 International License